Multiple sclerosis (MS) is an autoimmune and neurodegenerative disorder characterized by
chronic inflammation, demyelination, as well as axonal and neuronal loss in the central …

The gut environment and gut microbiome dysbiosis have been demonstrated to significantly
influence a range of disorders in humans, including obesity, diabetes, rheumatoid arthritis …

Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence
that varies considerably, from high levels in North America and Europe (> 100/100,000 …

Objectives Previous studies have demonstrated a strong latitudinal gradient in multiple
sclerosis (MS) prevalence. Herein, we present a meta-analysis of the latitudinal gradient of …

Multiple sclerosis (MS) is known to be a partially heritable autoimmune disease. The risk of
developing MS increases from typically 1 in 1,000 in the normal population to 1 in 4 or so for …

Objective We sought to better understand the reasons for increasing prevalence of multiple
sclerosis (MS) by studying prevalence in relation to incidence, mortality rates, sex ratio, and …

Although multiple sclerosis (MS) has been considered a white matter disease, MS lesions
occur frequently in the gray matter parts of the brain. Gray matter demyelination and atrophy …

Objective: Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …

Gut microbiota has essential roles in the prevention and progression of multiple sclerosis
(MS). The association between the gut microbiota and the central nervous system (CNS) or …

Background Low vitamin D and/or sun exposure have been associated with increased risk
of multiple sclerosis (MS) onset. However, comparatively, few studies have prospectively …